Perspectives in the treatment of breast cancer: 1976

R. C. Young, Marc E Lippman, V. T. DeVita

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Breast cancer is th major cancer killer of women in the USA. Recent advances in therapy promise more effective control of this illness. The development of hormone receptor analysis permits us to better understand the mechanisms of action of steroid and peptide hormones and increases the likelihood of using these hormonal agents effectively. Prospective surgical and surgical adjuvant trials offer the opportunity to define accurately the appropriate surgical procedure and most effective postoperative therapy after initial surgery. The development of chemotherapy, first singly and now in combination, has led to improved treatment of patients with advanced disease and defined better chemotherapy for use in adjuvant settings. The investigation of a matrix of marker substances in breast cancer may uncover new methods to assess residual disease and to monitor disease recurrence.

Original languageEnglish
Pages (from-to)784-798
Number of pages15
JournalAnnals of Internal Medicine
Volume86
Issue number6
StatePublished - Dec 1 1977
Externally publishedYes

Fingerprint

Breast Neoplasms
Drug Therapy
Peptide Hormones
Therapeutics
Steroids
Hormones
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Young, R. C., Lippman, M. E., & DeVita, V. T. (1977). Perspectives in the treatment of breast cancer: 1976. Annals of Internal Medicine, 86(6), 784-798.

Perspectives in the treatment of breast cancer : 1976. / Young, R. C.; Lippman, Marc E; DeVita, V. T.

In: Annals of Internal Medicine, Vol. 86, No. 6, 01.12.1977, p. 784-798.

Research output: Contribution to journalArticle

Young, RC, Lippman, ME & DeVita, VT 1977, 'Perspectives in the treatment of breast cancer: 1976', Annals of Internal Medicine, vol. 86, no. 6, pp. 784-798.
Young RC, Lippman ME, DeVita VT. Perspectives in the treatment of breast cancer: 1976. Annals of Internal Medicine. 1977 Dec 1;86(6):784-798.
Young, R. C. ; Lippman, Marc E ; DeVita, V. T. / Perspectives in the treatment of breast cancer : 1976. In: Annals of Internal Medicine. 1977 ; Vol. 86, No. 6. pp. 784-798.
@article{fd3fb6cd01f44c959ca84c0c76498716,
title = "Perspectives in the treatment of breast cancer: 1976",
abstract = "Breast cancer is th major cancer killer of women in the USA. Recent advances in therapy promise more effective control of this illness. The development of hormone receptor analysis permits us to better understand the mechanisms of action of steroid and peptide hormones and increases the likelihood of using these hormonal agents effectively. Prospective surgical and surgical adjuvant trials offer the opportunity to define accurately the appropriate surgical procedure and most effective postoperative therapy after initial surgery. The development of chemotherapy, first singly and now in combination, has led to improved treatment of patients with advanced disease and defined better chemotherapy for use in adjuvant settings. The investigation of a matrix of marker substances in breast cancer may uncover new methods to assess residual disease and to monitor disease recurrence.",
author = "Young, {R. C.} and Lippman, {Marc E} and DeVita, {V. T.}",
year = "1977",
month = "12",
day = "1",
language = "English",
volume = "86",
pages = "784--798",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

TY - JOUR

T1 - Perspectives in the treatment of breast cancer

T2 - 1976

AU - Young, R. C.

AU - Lippman, Marc E

AU - DeVita, V. T.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - Breast cancer is th major cancer killer of women in the USA. Recent advances in therapy promise more effective control of this illness. The development of hormone receptor analysis permits us to better understand the mechanisms of action of steroid and peptide hormones and increases the likelihood of using these hormonal agents effectively. Prospective surgical and surgical adjuvant trials offer the opportunity to define accurately the appropriate surgical procedure and most effective postoperative therapy after initial surgery. The development of chemotherapy, first singly and now in combination, has led to improved treatment of patients with advanced disease and defined better chemotherapy for use in adjuvant settings. The investigation of a matrix of marker substances in breast cancer may uncover new methods to assess residual disease and to monitor disease recurrence.

AB - Breast cancer is th major cancer killer of women in the USA. Recent advances in therapy promise more effective control of this illness. The development of hormone receptor analysis permits us to better understand the mechanisms of action of steroid and peptide hormones and increases the likelihood of using these hormonal agents effectively. Prospective surgical and surgical adjuvant trials offer the opportunity to define accurately the appropriate surgical procedure and most effective postoperative therapy after initial surgery. The development of chemotherapy, first singly and now in combination, has led to improved treatment of patients with advanced disease and defined better chemotherapy for use in adjuvant settings. The investigation of a matrix of marker substances in breast cancer may uncover new methods to assess residual disease and to monitor disease recurrence.

UR - http://www.scopus.com/inward/record.url?scp=0017750339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017750339&partnerID=8YFLogxK

M3 - Article

C2 - 869360

AN - SCOPUS:0017750339

VL - 86

SP - 784

EP - 798

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -